Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Loeffler

Showing results (221-230 of 329) with videos related to

Pageof 33
Sort By:
Circulation|December 7, 2005
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicityLeszek Wojnowski, Bettina Kulle, Markus Schirmer, et al.
The Lancet. Oncology|September 24, 2011
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) GroupMichael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, et al.
The Lancet. Haematology|February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.
Brain Communications|December 8, 2025
Retinal nerve fibre layer thickness is associated with attention and predicts risk states of dementiaMatthias L Schroeter, Johanna Girbardt, Tobias Luck, et al.
Gut|May 24, 2015
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancerMichael Kloth, Vanessa Ruesseler, Christoph Engel, et al.
Hemasphere|March 10, 2025
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLAKatrin S Kurz, Sophia Steinlein, Markus Kreuz, et al.
The New England Journal of Medicine|January 11, 2008
Intensive insulin therapy and pentastarch resuscitation in severe sepsisFrank M Brunkhorst, Christoph Engel, Frank Bloos, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Intensive Care Medicine|February 27, 2007
Epidemiology of sepsis in Germany: results from a national prospective multicenter studyChristoph Engel, Frank M Brunkhorst, Hans-Georg Bone, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Pageof 33

Showing results (221-230 of 329) with videos related to

Sort By:
Pageof 33
Circulation|December 7, 2005
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicityLeszek Wojnowski, Bettina Kulle, Markus Schirmer, et al.
The Lancet. Oncology|September 24, 2011
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) GroupMichael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper, et al.
The Lancet. Haematology|February 3, 2022
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Sandra Robrecht, et al.
Brain Communications|December 8, 2025
Retinal nerve fibre layer thickness is associated with attention and predicts risk states of dementiaMatthias L Schroeter, Johanna Girbardt, Tobias Luck, et al.
Gut|May 24, 2015
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancerMichael Kloth, Vanessa Ruesseler, Christoph Engel, et al.
Hemasphere|March 10, 2025
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLAKatrin S Kurz, Sophia Steinlein, Markus Kreuz, et al.
The New England Journal of Medicine|January 11, 2008
Intensive insulin therapy and pentastarch resuscitation in severe sepsisFrank M Brunkhorst, Christoph Engel, Frank Bloos, et al.
International Journal of Cancer|June 23, 2015
The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancerGunnar Wichmann, Maciej Rosolowski, Knut Krohn, et al.
Intensive Care Medicine|February 27, 2007
Epidemiology of sepsis in Germany: results from a national prospective multicenter studyChristoph Engel, Frank M Brunkhorst, Hans-Georg Bone, et al.
Haematologica|November 2, 2013
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphomaSietse M Aukema, Markus Kreuz, Christian W Kohler, et al.
Pageof 33